| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,060 |
5,420 |
$383K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,826 |
2,524 |
$179K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
843 |
698 |
$112K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,726 |
1,538 |
$103K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,450 |
1,335 |
$95K |
| 87428 |
|
1,464 |
1,334 |
$47K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
301 |
275 |
$22K |
| 80051 |
|
1,516 |
1,294 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,830 |
2,397 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
785 |
722 |
$15K |
| 80053 |
Comprehensive metabolic panel |
1,396 |
1,204 |
$15K |
| 81003 |
|
2,160 |
1,942 |
$13K |
| 81025 |
|
1,426 |
1,293 |
$11K |
| 84484 |
|
816 |
689 |
$8K |
| 82550 |
|
1,535 |
1,310 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
186 |
173 |
$7K |
| 82565 |
|
1,519 |
1,296 |
$6K |
| 70450 |
Computed tomography, head or brain; without contrast material |
93 |
81 |
$6K |
| 82947 |
|
1,737 |
1,392 |
$6K |
| 87420 |
|
103 |
96 |
$4K |
| 84520 |
|
1,511 |
1,291 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
74 |
67 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
58 |
46 |
$2K |
| 82977 |
|
384 |
351 |
$2K |
| 87634 |
|
73 |
66 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
89 |
80 |
$2K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
33 |
30 |
$2K |
| 82150 |
|
388 |
354 |
$2K |
| 84460 |
|
377 |
344 |
$2K |
| 84075 |
|
377 |
344 |
$1K |
| 84450 |
|
377 |
344 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
19 |
18 |
$1K |
| 82040 |
|
377 |
344 |
$1K |
| 82247 |
|
377 |
344 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
59 |
54 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
59 |
54 |
$1K |
| 84155 |
|
377 |
344 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,606 |
1,382 |
$422.89 |
| 83605 |
|
48 |
39 |
$384.04 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
16 |
15 |
$327.13 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
749 |
598 |
$312.89 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
76 |
71 |
$246.02 |
| 71045 |
Radiologic examination, chest; single view |
939 |
856 |
$204.40 |
| 85379 |
|
25 |
25 |
$191.81 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,156 |
945 |
$174.97 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
284 |
233 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
18 |
17 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
31 |
27 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,332 |
1,172 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
476 |
428 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
359 |
328 |
$0.00 |
| 73610 |
|
13 |
12 |
$0.00 |